Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants With Necrotizing Enterocolitis (NEC)
Clinical trial NCT06315738 · RECRUITING
Trial details
- NCT number
- NCT06315738
- Sponsor
- Noveome Biotherapeutics, formerly Stemnion
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-19
- Primary completion
- 2029-06-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.